Chrubasik J E, Roufogalis B D, Chrubasik S
Institute of Forensic Medicine, University of Freiburg im Breisgau, Albertstr. 9 79104 Freiburg im Breisgau, Germany.
Phytother Res. 2007 Jul;21(7):675-83. doi: 10.1002/ptr.2142.
Treatment with herbal medicines is very popular in Europe. In order to get information on the evidence of effectiveness of oral herbal medicines in the treatment of pain in the joints or lower back, OVID(MEDLINE), PUBMED and COCHRANE COLLABORATION LIBRARY were searched back to 1985 for systematic reviews. The level of evidence of effectiveness was defined as strong - at least two confirmatory studies demonstrating a clinical relevant effect, moderate - one confirmatory study with a clinical relevant effect and/or multiple exploratory studies of good quality; otherwise the evidence was insufficient or conflicting in the case of inconsistent findings. Fifteen systematic reviews were identified. The evidence of effectiveness was strong for a proprietary unsaponifiable avocado soybean fraction and Harpagophytum preparations containing > 50 mg harpagoside in the daily dosage, moderate for ginger and a proprietary rose hip and seed powder, insufficient for Boswellia serrata gum resin and other herbal preparations and inconsistent for a proprietary willow bark extract. Further rigorous studies are required to confirm the usefulness of herbal medicines in the treatment of osteoarthritic complaints and chronic low back pain in order to enable acceptance of the herbal medicines into the treatment guidelines.
草药治疗在欧洲非常流行。为了获取关于口服草药治疗关节或下背部疼痛有效性的证据,对OVID(医学索引数据库)、PUBMED和考克兰协作图书馆进行了检索,检索时间回溯至1985年以查找系统评价。有效性证据水平被定义为:强——至少两项确证性研究证明有临床相关效果;中——一项有临床相关效果的确证性研究和/或多项高质量的探索性研究;否则,若结果不一致,则证据不足或相互矛盾。共识别出15项系统评价。对于一种专利非皂化鳄梨大豆提取物以及每日剂量中含有超过50毫克哈帕苷的南非钩麻制剂,有效性证据为强;对于生姜以及一种专利玫瑰果和种子粉,有效性证据为中;对于乳香树脂和其他草药制剂,有效性证据不足;对于一种专利柳树皮提取物,有效性证据相互矛盾。需要进一步进行严格研究,以证实草药在治疗骨关节炎症状和慢性下背痛方面的有效性,从而使草药能够被纳入治疗指南。